Development and commercial launch of media for CHO and HEK293 cells
First written in FY2024. 2 of 4 entries say "Advanced", first in FY2025. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「In November 2025, the company completed its internal review of a medium for transfecting CHO cells, scheduled for launch in the fiscal year ending March 2027, and commissioned an external specialist organisation to conduct performance testing. The test results were reported in 2026 and were favourable, but testing of antibody activity and other properties is expected to take somewhat longer, so the launch is expected to take place in the next fiscal year.」
The new CHO cell product has progressed to the stage where the internal review is complete and favourable results have been obtained from external testing. The HEK293 cell medium remains scheduled for launch in the following fiscal year. - 2026-05-15AchievedManagement Planning
「 CHO細胞、HEK293細胞の開発及び上市」
従来の上市予定に対し、本資料ではCHO細胞用培地を2023年、HEK293細胞用培地を2024年に上市した実績としてロードマップ上に記載している。 - FY2025AdvancedAnnual report
「The medium for CHO cells is currently on the market. Development of the medium for culturing HEK293 cells is also progressing smoothly, and a launch is planned for the following fiscal year.」
Since the previous stage, when launch preparations were under way, the medium for CHO cells has been launched. The medium for HEK293 cells remains scheduled for launch in the following fiscal year. - FY2024First statedAnnual report
「The company is currently preparing to launch its medium for CHO cells. Development of its medium for culturing HEK293 cells is also progressing smoothly, and a launch is planned for the following fiscal year.」
The company is prioritising the development of chemically defined media for industrial applications. The CHO cell medium is in launch preparation, while the HEK293 cell medium is scheduled for launch in the following fiscal year.